Non-safety-related voluntary market withdrawal of a limited portion of DAYTRANA (methylphenidate transdermal system) pat
This is a discussion on Non-safety-related voluntary market withdrawal of a limited portion of DAYTRANA (methylphenidate transdermal system) pat within the FDA Recalls, Market Withdrawals and Safety Alerts forum, part of the Industry News and Updates category; Shire is taking this action because some DAYTRANA patches no longer meet their release liner removal specification, and as a ...
|
|||||||
| Register | Help | Members List | Mark Forums Read |
03-23-2009, 01:31 PM
|
|||
|
|||
Non-safety-related voluntary market withdrawal of a limited portion of DAYTRANA (methylphenidate transdermal system) pat
Shire is taking this action because some DAYTRANA patches no longer meet their release liner removal specification, and as a result, patients and caregivers could have difficulties removing the liners.
More... 
|
 |
«
Previous Thread
|
Next Thread
»
| Thread Tools | |
| Display Modes | |
Linear Mode
|
|
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| Potential Signals of Serious Risks/New Safety Information Identified by the Adverse Event Reporting System (AERS) | industry_news | FDA News | 0 | 09-05-2008 03:28 PM |
| Potential Signals of Serious Risks/New Safety Information Identified by the Adverse Event Reporting System (AERS): Janua | industry_news | FDA News | 0 | 09-05-2008 03:28 PM |
| Watson Pharmaceuticals, Inc. issues a voluntary recall of one lot of 75mcg/hr Fentanyl Transdermal System patches | industry_news | FDA News | 0 | 08-13-2008 10:40 AM |
| PriCara Recalls 25 mcg/hr DURAGESIC (fentanyl transdermal system) CII Pain Patches (F | industry_news | FDA Recalls, Market Withdrawals and Safety Alerts | 0 | 02-26-2008 03:30 PM |
| Bayer and FDA inform healthcare professionals of the market withdrawal of the current | industry_news | FDA News | 0 | 02-26-2008 03:30 PM |
© 2008 DrugManagementForum™ powered by |
 |